Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study - Roy Vitkon, Dan Netanely, Shai Levi, Tomer
Frontiers | Daratumumab for the Treatment of Multiple Myeloma
Clearing drug interferences in myeloma treatment using mass spectrometry - ScienceDirect
Case 966-- Clinical Chemistry Case
Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for IgG kappa multiple myeloma | Bone Marrow Transplantation
Patient 1 with a history of IgG kappa multiple myeloma presented with... | Download Scientific Diagram
Immunoelectrophoresis ofproducts released after treatment ofIgG-bearing... | Download Scientific Diagram
Human IgG Kappa MAb HTRF kit | Cisbio
Frontiers | Molecular Landscape of Anti-Drug Antibodies Reveals the Mechanism of the Immune Response Following Treatment With TNFα Antagonists
Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis
PathPointer: Membranous-Like Glomerulopathy With Masked IgG Kappa Deposits – AJKD Blog
Different antibody-based therapies for treatment of multiple myeloma:... | Download Scientific Diagram
British Journal of Haematology | Wiley Online Library
Anti Human Kappa Chain, made in goat, AMCA labeled x human
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis | NEJM
Unlabeled Anti-Mouse Kappa, 187.1 | SouthernBiotech
Serum immunofixation electrophoresis revealed an IgG kappa monoclonal... | Download Scientific Diagram
Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference
Monoclonal gammopathy of undetermined significance: A primary care guide | Cleveland Clinic Journal of Medicine
Patient Case 3: A 79-Year-Old Female With IgG Kappa Multiple Myeloma
Diagnostics | Free Full-Text | Decreased Intrathecal Concentrations of Free Light Chains Kappa in Multiple Sclerosis Patients Taking Very High Effective Disease-Modifying Treatment
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference
